FDA Approves Afinitor for Advanced Breast Cancer Brevard Times The U.S. Food and Drug Administration on Friday approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. ... “This is ... |
